Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Therapeutic Potential of Convalescent Plasma Therapy on Treating Critically-ill COVID-19 Patients Residing in Respiratory Care Units in Hospitals in Baghdad, Iraq

NCT04441424 is registered in ClinicalTrials.gov with Alkarkh Health Directorate-Baghdad as lead sponsor.

NCT NCT04441424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04441424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Therapeutic Potential of Convalescent Plasma Therapy on Treating Critically-ill COVID-19 Patients Residing in Respiratory Care Units in Hospitals in Baghdad, Iraq
Lead sponsor
Alkarkh Health Directorate-Baghdad
Phase
Not applicable
Overall status
Completed
Start date
April 3, 2020
Completion date
June 1, 2020
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunotherapy